Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

We list the best IDE for Python, to make it simple and easy for programmers to manage their Python code with a selection of specialist tools. An Integrated Development Environment (IDE) allows you to ...

For decades, artificial intelligence advanced in careful, mostly linear steps. Researchers built models. Engineers improved performance. Organizations deployed systems to automate specific tasks. Each ...

Although naturally occurring proteins form stable defined tertiary structures, it is well known that many proteins with non-natural sequences have unstructured conformations 1,2. This suggests that ...

Abstract: A new approach to the permutation problem for Blind Source Separation (BSS) in the frequency domain is presented. The independence of the separation across the frequencies, and thus the ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

For privacy reasons, the public repository does not contain any real patient‑level values or even simulated values. The files in data_example/ are templates: they contain column headers only, ...